E-LIB Suche - Ergebnisse für: Rivero, O.

1

Eisenstein congruences among Euler systems:

Rivero, Ó. ; Rotger, V.
Canadian Mathematical Bulletin. 67 (2023) 2 - p. 425-446 , 2023

Link: https://doi.org/10.4153/..

2

Identification of blood and neuronal biomarkers for disease..:

Rivero, O. ; McKenzie, K. ; Lluesma, J. David...
Neuroscience Applied. 2 (2023) - p. 103333 , 2023

Link: https://doi.org/10.1016/..

3

Una nueva galería decorada en la cueva de Alkerdi 2 (Urdazu..:

Garate, D. ; Rivero, O. ; Hermoso de Mendoza, A....
Trabajos de Arqueología Navarra. , 2022

Link: https://doi.org/10.35462..

4

Arte parietal paleolítico de la cueva de Alkerdi 2 (Urdazub..:

Garate, D. ; Rivero, O. ; Hermoso de Mendoza, A....
Trabajos de Arqueología Navarra. , 2021

Link: https://doi.org/10.35462..

5

P.0021 Deficiency of Cadherin 13, a ADHD risk gene, impacts..:

Ku, H.P. ; Forero, A. ; Rivero, O..
European Neuropsychopharmacology. 53 (2021) - p. S16-S17 , 2021

Link: https://doi.org/10.1016/..

6

Cadherin-13, a risk factor for neurodevelopmental disorders..:

Forero, A. ; Rivero, O. ; Wäldchen, S....
European Neuropsychopharmacology. 27 (2017) - p. S615 , 2017

Link: https://doi.org/10.1016/..

7

Cadherin-13 at the intersection between serotonergic neuron..:

Forero, A. ; Wäldchen, S. ; Rivero, O....
European Neuropsychopharmacology. 27 (2017) - p. S15-S16 , 2017

Link: https://doi.org/10.1016/..

8

Cadherin-13, a risk factor for neurodevelopmental disorders..:

Forero, A. ; Rivero, O. ; Kiser, D.P....
European Neuropsychopharmacology. 27 (2017) - p. S538 , 2017

Link: https://doi.org/10.1016/..

9

P.7.a.001 Effect of cadherin-13 inactivation on hippocampal..:

Sich, S. ; Rivero, O. ; Popp, S....
European Neuropsychopharmacology. 25 (2015) - p. S634 , 2015

Link: https://doi.org/10.1016/..

10

Cadherin-13, a risk gene for ADHD and comorbid disorders, i..:

Rivero, O ; Selten, M M ; Sich, S...
Translational Psychiatry. 5 (2015) 10 - p. e655-e655 , 2015

Link: https://doi.org/10.1038/..

11

The genetic contribution of the NO system at the glutamater..:

Weber, H. ; Klamer, D. ; Freudenberg, F....
European Neuropsychopharmacology. 24 (2014) 1 - p. 65-85 , 2014

Link: https://doi.org/10.1016/..

12

Enterprise Liability, Risk Pooling, and Diagnostic Care:

Fenn, P. ; Gray, A. ; Rickman, N....
Journal of Public Administration Research and Theory. 20 (2010) Supplement 2 - p. i225-i242 , 2010

Link: https://doi.org/10.1093/..

13

El colgajo romboidal de Limberg en el tratamiento del quist..:

Renart, I. ; Gómez, C. ; Pujals, J..
Revista Iberoamericana de Cirugía de la Mano. 36 (2008) 2 - p. 107-112 , 2008

Link: https://doi.org/10.1055/..

14

BRAIN MORPHOMETRY IN SCHIZOPHRENIA: EFFECTS OF 5-HTTLPR POL..:

Arcía-Martí, G. ; Escartí-Fabra, M.J. ; García-Iturrospe, E.J. Aguilar...
Schizophrenia Research. 102 (2008) 1-3 - p. 79 , 2008

Link: https://doi.org/10.1016/..

15

Vinorelbine (VNB) + ifosfamide (IFX) in non operable non sm..:

Rivero, O. ; Lozano, M. ; Polera, J....
European Journal of Cancer. 35 (1999) - p. S261 , 1999

Link: https://doi.org/10.1016/..